EUVIMEDOpdag EUVIMED
Crossref

Tanshinone IIA attenuates ox‐LDL ‐induced endothelial cell injury by inhibiting NF‐kapaB pathway via circ_0000231/ miR ‐590‐5p/ TXNIP axis

Zhu Chen, Jiaai Zhao, Siwang Wang, Qiang Li

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14394 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2024. Written by Zhu Chen and 3 co-authors. Institution: Department of Neurology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China. Major MEDLINE topics: Endothelial Cells, MicroRNAs, Abietanes. Cited 8 times so far (Crossref); 36 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Tanshinone IIA (TSIIA) exhibits inhibitory function in atherosclerosis (AS) progression, and circular RNAs (circRNAs) are pivotal regulators in AS. However, the relation between TSIIA and circ_0000231 in AS pathogenesis remains unknown. In this study, oxidized low‐density lipoprotein (ox‐LDL) was used to establish AS cell model. Treatment of ox‐LDL inhibited cell growth but promoted apoptosis, inflammation, and oxidative stress. Then, TSIIA was shown to attenuate ox‐LDL‐induced endothelial injury. Furthermore, the protective effect of TSIIA against ox‐LDL‐induced endothelial cell injury was reversed by circ_0000231. Circ_0000231 was identified as a miR‐590‐5p sponge. Also, miR‐590‐5p downregulation restored the protection of TSIIA for endothelial cell function. Moreover, circ_0000231 was found to upregulate thioredoxin interacting protein (TXNIP) level via targeting miR‐590‐5p. TXNIP overexpression mitigated the regulatory function of circ_0000231 knockdown after co‐treatment with ox‐LDL and TSIIA. TXNIP upregulation recovered the inhibitory regulation of TSIIA in ox‐LDL‐induced cell damage. In addition, TSIIA inactivated NF‐kapaB (NF‐κB) signaling pathway via regulating miR‐590‐5p/TXNIP axis by downregulating circ_0000231. All these results suggested that TSIIA inhibited ox‐LDL‐induced AS progression in endothelial cells by affecting NF‐κB pathway via circ_0000231/miR‐590‐5p/TXNIP.

Subjects

MeSH terms (MEDLINE)

Endothelial CellsMicroRNAsAbietanesHumansNF-kappa BLipoproteins, LDLApoptosisCell ProliferationHuman Umbilical Vein Endothelial Cells

Author keywords

NF-kapaB pathwayTXNIPTanshinone IIAatherosclerosiscirc_0000231miR-590-5p

Substances

tanshinoneoxidized low density lipoproteinNF-kappa BLipoproteins, LDLMicroRNAsAbietanes

Authors and institutions

  • Department of Neurology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
  • Department of Cardiology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.

Cite

APA

Chen, Z., Zhao, J., Wang, S., & Li, Q. (2024). Tanshinone IIA attenuates ox‐LDL ‐induced endothelial cell injury by inhibiting NF‐kapaB pathway via circ_0000231/ miR ‐590‐5p/ TXNIP axis. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14394

Vancouver

Chen Z, Zhao J, Wang S, Li Q. Tanshinone IIA attenuates ox‐LDL ‐induced endothelial cell injury by inhibiting NF‐kapaB pathway via circ_0000231/ miR ‐590‐5p/ TXNIP axis. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14394

BibTeX
@article{Chen2024,
  author = {Chen, Zhu and Zhao, Jiaai and Wang, Siwang and Li, Qiang},
  title = {Tanshinone IIA attenuates ox‐LDL ‐induced endothelial cell injury by inhibiting NF‐kapaB pathway via circ_0000231/ miR ‐590‐5p/ TXNIP axis},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14394}
}
Start for free →